Abstract:The sulfur-containing amino acid, homocysteine, is formed from the essential amino acid methionine, and a number of B vitamins are involved in methionine metabolism. Pyridoxine, vitamin B6, is a cofactor for cystathionine beta synthase, which mediates the transformation of homocysteine to cystathionine, the initial step in the transsulfuration pathway and the urinary excretion of sulfur. In a normal diet there is conservation of the carbon skeleton, and about 50% of the homocysteine formed is remethylated to methionine via steps that require folic acid and vitamin B12. A deficiency of any of these three vitamins leads to modest homocyst(e)ine elevation, as does diminished renal function, both of which are common in the elderly. It is also established that homocyst(e)ine elevation of this order is associated with increased cardiovascular risk but is also associated with most established risk factors, although it is thought to be an independent contributor. In the inborn error of metabolism homocystinuria due to cystathionine beta synthase deficiency there is greatly increased circulating homocyst(e)ine and a clear association with precocious vascular disease. In about 50% of these patients there is a vascular event before the age of 30 years. The homocysteine-induced adverse vascular changes appear to result from endothelial and smooth muscle cell effects and increased thrombogenesis. We have documented a highly significant reduction in the occurrence of vascular events during 539 patient years of treatment in 32 patients with cystathionine beta synthase deficiency (mean age 30 years, range 9-66 years) by aggressive homocyst(e)ine lowering with pyridoxine, folic acid, and B12 (p = 0.0001). The 15 pyridoxine nonresponsive patients also received oral betaine. Although a cause and effect relationship is postulated for the increased cardiovascular risk associated with mild homocysteine elevation, a common cause of this elevation is the methylenetetrahydrofolate reductase C677T mutation. Homozygotes occur in about 11% of Caucasian populations. However, the mutation is not associated with increased coronary risk. Since mild homocysteine elevation is easily normalized by B vitamin supplementation, usually with folic acid, it remains for controlled clinical trials of this inexpensive therapy to determine whether normalizing mild homocyst(e)ine elevation reduces cardiovascular risk.

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Hyperhomocysteinemia and its effect on ageing and language functions – HEAL study

Homocysteine, white matter hyperintensities, and cognition in healthy elderly people

Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease

Low and High Homocysteine Are Associated with Mortality Independent of B Group Vitamins but Interactive with Cognitive Status in a Free-Living Elderly Cohort

Abstract 69: Epigenetic Age and Brain Health Events: Findings From the Health and Retirement Study

Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men

Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults

Association of Elevated Plasma Total Homocysteine With Dementia With Lewy Bodies: A Case-Control Study

Homocysteine, cerebrovascular disease and brain atrophy

Hyperhomocysteinemia and Risk of Cognitive Decline: A Meta-Analysis of Prospective Cohort Studies

Plasma homocysteine and longitudinal change in cognitive function among urban adults

Homocysteine and Folic Acid: Risk Factors for Alzheimer's Disease—An Updated Meta-Analysis

Homocysteine Accelerates Senescence of Endothelial Cells Via DNA Hypomethylation of Human Telomerase Reverse Transcriptase.

B-vitamins and homocysteine in Spanish institutionalized elderly

Homocysteine is Associated with the Development of Cerebral Small Vessel Disease: Retrospective Analyses from Neuroimaging and Cognitive Outcomes

B vitamins and homocysteine in cardiovascular disease and aging

Homocysteine Induces Inflammation in Retina and Brain

Abstract P304: Association of Epigenetic Age Acceleration With Cognition in the Bogalusa Heart Study

Homocysteine as a risk factor for cognitive impairment in stroke patients

Relationship of Plasma Homocysteine and the Gene Polymorphisms of Metabolic Enzymes with Alzheimer's Disease